Clinical Trials Directory

Trials / Completed

CompletedNCT02909465

Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation

A Comparison of Midazolam or Haloperidol Premedication Versus Placebo for Reducing Ketamine Induced Agitation After Adult Procedural Sedation in the Emergency Department

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
185 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Ketamine is the cornerstone of procedural sedation in emergency department but ketamine induced agitation has limited its usage by many physicians. As a solution, some propose using midazolam or haloperidol before ketamine injection. In this randomized double blind clinical trial, patients who are eligible for sedation by ketamine are allocated in 3 groups. In first group, the patients will receive 0.05 mg/kg midazolam, in second group 5 mg of haloperidol and in 3rd group a placebo five minutes before receiving the sedative dose of ketamine (1 mg/kg). The patients are assessed for agitation during and after the procedure the clinician's satisfaction with sedation instrument is evaluated after the procedure.

Detailed description

Ketamine is the cornerstone of procedural sedation in emergency department but ketamine induced agitation has limited its usage by many physicians. As a solution, some propose using midazolam or haloperidol before ketamine injection. In this randomized double blind clinical trial, patients who are eligible for sedation by ketamine are allocated in 3 groups. In first group, the patients will receive 0.05 mg/kg midazolam, in second group 5 mg of haloperidol and in 3rd group a placebo five minutes before receiving the sedative dose of ketamine (1 mg/kg). The patients are assessed for agitation during and after the procedure the clinician's satisfaction with sedation instrument is evaluated after the procedure. The investigator will fill standard questionnaires for agitation assessment (Richmond Agitation-Sedation Scale and Pittsburgh Agitation Scale).

Conditions

Interventions

TypeNameDescription
DRUGMidazolamUsing Midazolam as a premedication for reducing ketamine-induced agitation
DRUGHaloperidolUsing Haloperidol as a premedication for reducing ketamine-induced agitation
DRUGplacebodistilled water
DRUGKetamineKetamine is routinely used for all procedural sedation in the patients.

Timeline

Start date
2016-07-01
Primary completion
2017-04-01
Completion
2017-07-01
First posted
2016-09-21
Last updated
2017-11-07

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02909465. Inclusion in this directory is not an endorsement.

Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation (NCT02909465) · Clinical Trials Directory